Finding the hidden millions: identifying undiagnosed, symptomatic COPD through lung cancer screening (the FRONTIER Programme) - Vienna 2024

Chronic obstructive pulmonary disease comorbidities: novelties in an old link!

Chair(s): Bianca Begh, Lowie Vanfleteren

Session type: Poster session

Finding the hidden millions: identifying undiagnosed, symptomatic COPD through lung cancer screening (the FRONTIER Programme)

Kayleigh Brindle

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Cardiovascular risk after hospitalization for exacerbation of COPD

Lia Alonso Tom

Poster

Abstract

Air trapping and the risk of cardiovascular events in COPD exacerbations.

Anastasia Papaporfyriou

Poster

Abstract

The prevalence of EGFR mutations in lung adenocarcinoma patients with COPD: a middle income country experience

Ivana Canak

Poster

Abstract

Impact of COPD on the Follow-up of Patients with Acute Coronary Syndrome.

Santiago Rodriguez-segade Alonso

Abstract

Endothelial dysfunction and coronary artery disease in patients with COPD

Mairi Macleod

Poster

Abstract

Inflammatory profile of COPD reached by hypertension

Ouahida Bouroubi

Poster

Abstract

Characteristics of COPD patients experiencing cardiovascular events during hospitalization for COPD exacerbation

Stavroula Zaneli

Poster

Abstract

Does raised troponin during severe COPD exacerbation predict future cardiovascular events?

Nyle Cockell

Poster

Abstract

The differences in Electrocardiography (ECG) according to the severity of Chronic Obstructive Pulmonary Disease

Eun Yeong Cho

Poster

Abstract

Lung Cancer Burden in the SPIROMICS Cohort.

Igor Barjaktarevic

Poster

Abstract

The effect of tiotropium/olodaterol fixed-dose combination on cardiac function in patients with newly diagnosed moderate-to-severe chronic obstructive pulmonary disease

Ieva Dimiene

Poster

Abstract

The interplay between COPD and chronic heart failure deterioration

Sanne H B Van Dijk

Poster

Abstract

COPD exacerbations and cardiovascular comorbidities

Lucile Regard

Poster

Abstract

Prevalence of cardiovascular disease in COPD and AATD-COPD

Paul Ellis

Poster

Abstract

Finding the hidden millions: identifying undiagnosed, symptomatic COPD through lung cancer screening (the FRONTIER Programme)

Kayleigh Brindle

Poster

Abstract

Significant Different Levels of CO2, NO2, CO, C6H6, and C3H8 and Serum Leukotriene B4 Between COPD versus COPD with Lung Cancer Patients

Dr. Dr. Susanthy Djajalaksana, Sp.p

Poster

Abstract

The predictive value of eosinophil levels on structural and functional changes in the left ventricle in COPD combined with hypertension

Anastasiia Melenevych

Poster

Abstract

Dysregulated serum glycerophospholipid and fatty acid metabolism in different disease stages of COPD

Yan Yu

Poster

Abstract

Does PRISm or Pre-COPD affect cardiovascular outcomes among COPD-patients in the Swedish National Airway Register?

Oskar Wallstr?m

Poster

Abstract

Erythropoiesis disorders in COPD

Wissal Bouddine

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}